drugset / Trial / NCT01295450

Study to Evaluate the Efficacy and Tolerability of Apevinat BC Compared to Vitamin Complex

NCT01295450

Phase 3 Unknown 74 enrolled MDCPharma Produtos Farmaceuticos LTDA
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of this study is to evaluate the efficacy and tolerability of Apevinat BC compared to vitamin complex, in the treatment of lack of appetite and prevention of deficiency of B and C vitamins.

Timeline

Start
2011-04
Primary completion
2011-08
Completion
2011-08

Drugs

EvaluationDrugModalityDoseRoute
Subject B1 Unknown
Subject B2 Unknown
Subject B3 Unknown
Subject C Unknown
Comparator Cyproheptadine Small molecule 0.8 mg
Comparator Nicotinamide Other / unclassified 1.334 mg
Comparator Riboflavin Other / unclassified 0.2 mg
Comparator Vitamin C Other / unclassified 4.334 mg
Comparator piridoxin hydrochloride Unknown 0.134 mg
Comparator tiamin hydrochloride Unknown 0.12 mg

Indications